HUT70749A - Anti-allergic pharmaceutical composition containing suplatast-tosilate for ophthalmic topical administracion and process for producing them - Google Patents

Anti-allergic pharmaceutical composition containing suplatast-tosilate for ophthalmic topical administracion and process for producing them Download PDF

Info

Publication number
HUT70749A
HUT70749A HU9401434A HU9401434A HUT70749A HU T70749 A HUT70749 A HU T70749A HU 9401434 A HU9401434 A HU 9401434A HU 9401434 A HU9401434 A HU 9401434A HU T70749 A HUT70749 A HU T70749A
Authority
HU
Hungary
Prior art keywords
pharmaceutical composition
ige antibody
eye
allergy
allergic
Prior art date
Application number
HU9401434A
Other languages
English (en)
Hungarian (hu)
Other versions
HU9401434D0 (en
Inventor
Takahiro Ogawa
Fuminori Tokumochi
Hitoshi Ohmori
Atsushi Okumura
Original Assignee
Senju Pharma Co
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co, Taiho Pharmaceutical Co Ltd filed Critical Senju Pharma Co
Publication of HU9401434D0 publication Critical patent/HU9401434D0/hu
Publication of HUT70749A publication Critical patent/HUT70749A/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HU9401434A 1993-05-14 1994-05-06 Anti-allergic pharmaceutical composition containing suplatast-tosilate for ophthalmic topical administracion and process for producing them HUT70749A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11279593 1993-05-14

Publications (2)

Publication Number Publication Date
HU9401434D0 HU9401434D0 (en) 1994-08-29
HUT70749A true HUT70749A (en) 1995-10-30

Family

ID=14595714

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9401434A HUT70749A (en) 1993-05-14 1994-05-06 Anti-allergic pharmaceutical composition containing suplatast-tosilate for ophthalmic topical administracion and process for producing them

Country Status (11)

Country Link
US (1) US5475033A (forum.php)
EP (1) EP0624367A1 (forum.php)
KR (1) KR0160538B1 (forum.php)
CN (1) CN1103782A (forum.php)
AU (1) AU679043B2 (forum.php)
BR (1) BR9401965A (forum.php)
CA (1) CA2123367C (forum.php)
HU (1) HUT70749A (forum.php)
PL (1) PL175375B1 (forum.php)
RU (1) RU2107497C1 (forum.php)
TW (1) TW264385B (forum.php)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5886045A (en) * 1995-04-24 1999-03-23 Taiyo Pharmaceutical Co., Ltd. Remedy for allergic diseases in the region of the nose
RU2123327C1 (ru) * 1996-05-27 1998-12-20 Вилен Гургенович Петросян Капли петросяна n 1 (n 2 - n 7 их варианты) для лечения аллергических и неатопических заболеваний глаз и носа
RU2123840C1 (ru) * 1996-05-27 1998-12-27 Петросян Вилен Гургенович Капли петросяна n 1a (n 2a - n 7a их варианты) для лечения аллергических и неатопических заболеваний глаз и носа
RU2123839C1 (ru) * 1996-05-27 1998-12-27 Вилен Гургенович Петросян Капли петросяна n 1б (2б-7б их варианты) для лечения аллергических и неатопических заболеваний глаз и носа
CA2317530C (en) 1998-11-05 2004-04-27 Taiho Pharmaceutical Co., Ltd. Dysuria remedies
ATE381538T1 (de) * 2001-04-16 2008-01-15 Taiho Pharmaceutical Co Ltd Suplatast tosilat kristalle
JP2004524375A (ja) * 2001-05-03 2004-08-12 ノバルティス アクチエンゲゼルシャフト 有機化合物の使用
RU2238088C1 (ru) * 2003-10-02 2004-10-20 Государственное предприятие Институт иммунологии Федерального управления медико-биологических и экстремальных проблем при Министерстве здравоохранения РФ N, n-диэтилдитиокарбаминовой кислоты натриевая соль, обладающая противоаллергическим действием
WO2010141883A1 (en) * 2009-06-04 2010-12-09 The Regents Of The University Of Colorado Compounds that modulate autoimmunity and methods of using the same
US9629848B2 (en) 2011-05-26 2017-04-25 The Regents Of The University Of Colorado, A Body Corporate Compounds that modulate autoimmunity and methods of using the same
WO2013188217A1 (en) * 2012-06-11 2013-12-19 Macuclear, Inc. Therapeutic formulation and methods of treatment
EP3247384B1 (en) 2015-01-14 2023-10-04 The Regents of the University of Colorado, a body corporate In vitro method of diagnosis of type 1 diabetes with insulin mimotopes
US9820957B2 (en) 2016-03-24 2017-11-21 The Regents Of The University Of Colorado, A Body Corporate Methods of treating autoimmunity
US11052060B2 (en) 2018-02-12 2021-07-06 The Regents Of The University Of Colorado, A Body Corporate Compounds and methods for treating autoimmunity
US11013707B2 (en) 2018-03-23 2021-05-25 The Regents Of The University Of Colorado, A Body Corporate Administration of oral methyldopa

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2523976B1 (fr) * 1982-03-26 1985-08-30 Pasteur Institut Nouveau produit proteique, obtention et application comme medicament, en particulier immunoregulateur et antiallergique
US4556737A (en) * 1983-03-11 1985-12-03 Taiho Pharmaceutical Company Limited Sulfonium compounds, processes for preparing the compounds and pharmacological composiitons containing the same
US4691018A (en) * 1985-05-23 1987-09-01 Chugai Seiyaku Kabushiki Kaisha Pyridine derivatives and their use as anti-allergic agents
US5157052A (en) * 1990-12-27 1992-10-20 Monsanto Company Method for inhibiting ige production
US5289036A (en) * 1991-01-22 1994-02-22 Nec Corporation Resin sealed semiconductor integrated circuit

Also Published As

Publication number Publication date
CA2123367C (en) 1998-04-14
AU679043B2 (en) 1997-06-19
EP0624367A1 (en) 1994-11-17
PL175375B1 (pl) 1998-12-31
RU2107497C1 (ru) 1998-03-27
RU94016184A (ru) 1996-05-20
HU9401434D0 (en) 1994-08-29
KR0160538B1 (ko) 1998-12-01
CN1103782A (zh) 1995-06-21
CA2123367A1 (en) 1994-11-15
US5475033A (en) 1995-12-12
TW264385B (forum.php) 1995-12-01
BR9401965A (pt) 1994-12-13
AU6193494A (en) 1994-11-17

Similar Documents

Publication Publication Date Title
US4910225A (en) Locally administrable therapeutic composition for inflammatory disease
HUT70749A (en) Anti-allergic pharmaceutical composition containing suplatast-tosilate for ophthalmic topical administracion and process for producing them
US5614545A (en) Topical composition for treatment of blepharitis
JPH01104023A (ja) 眼用保存製剤およびその製法
EP0642789A1 (en) Remedy for glaucoma
SK282403B6 (sk) 2,4-Disulfonyl-alfa-fenyl-terc-butylnitrón alebo jeho farmaceuticky prijateľná soľ, farmaceutický prostriedok s ich obsahom a ich použitie
JPH03181422A (ja) 炎症の治療方法及び炎症の治療用合成薬
JP2746832B2 (ja) 眼局所抗アレルギー剤
US5198454A (en) Use of OB-104 to treat ocular inflammation
WO1993010790A1 (en) The use of ob-101 to treat inflammation
EP3383403B1 (fr) Dérivés aminophosphiniques pour la prévention et le traitement des douleurs oculaires
US6339104B1 (en) Therapeutic agent for primary biliary cirrhosis
HU215959B (hu) Eljárás 5-metil-izoxazol-4-karbonsav-anilideket vagy 2-hidroxi-etilidén ciano-ecetsav-anilideket tartalmazó, szembetegségek kezelésére helyileg alkalmazható gyógyszerkészítmények előállítására
CA2089657C (en) Topical treatment of blepharitis
CA2152191C (en) Therapeutic agent for glaucoma and ocular hypotensive agent
IT9020968A1 (it) Composto farmaceutico a base di un antocianidina per il trattamento di malattie oftalmiche
US6077839A (en) Method for reducing intraocular pressure in the mammalian eye by administration of gamma aminobutyric acid (GABA) agonists
KR20010083123A (ko) 알레르기 질환 치료제
US5886045A (en) Remedy for allergic diseases in the region of the nose
AU778148B2 (en) 2-aminotetralin derivatives for the therapy of glaucoma
JPS63101352A (ja) 眼科治療用組成物
EP0885612A1 (en) Pirenoxine for the topical treatment of inflammatory conditions
US4230725A (en) Antiviral agent
JPH0624978A (ja) 抗アレルギー剤
JPH0435444B2 (forum.php)